16-56191124-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000665141.2(GNAO1-DT):​n.47+439C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.082 in 149,136 control chromosomes in the GnomAD database, including 553 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.082 ( 553 hom., cov: 31)
Exomes 𝑓: 0.071 ( 0 hom. )

Consequence

GNAO1-DT
ENST00000665141.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0580

Publications

2 publications found
Variant links:
Genes affected
GNAO1-DT (HGNC:27543): (GNAO1 divergent transcript)
GNAO1 (HGNC:4389): (G protein subunit alpha o1) The protein encoded by this gene represents the alpha subunit of the Go heterotrimeric G-protein signal-transducing complex. Defects in this gene are a cause of early-onset epileptic encephalopathy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
GNAO1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 17
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • movement disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • neurodevelopmental disorder with involuntary movements
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 16-56191124-G-A is Benign according to our data. Variant chr16-56191124-G-A is described in ClinVar as [Benign]. Clinvar id is 1238856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNAO1-DTNR_027078.2 linkn.-30C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNAO1-DTENST00000665141.2 linkn.47+439C>T intron_variant Intron 1 of 3
GNAO1ENST00000714052.1 linkn.102-1134G>A intron_variant Intron 1 of 2
GNAO1-DTENST00000715694.1 linkn.1976+1419C>T intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0820
AC:
12219
AN:
149002
Hom.:
552
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.0989
Gnomad AMR
AF:
0.0503
Gnomad ASJ
AF:
0.0461
Gnomad EAS
AF:
0.0342
Gnomad SAS
AF:
0.0937
Gnomad FIN
AF:
0.110
Gnomad MID
AF:
0.0321
Gnomad NFE
AF:
0.0754
Gnomad OTH
AF:
0.0586
GnomAD4 exome
AF:
0.0714
AC:
2
AN:
28
Hom.:
0
Cov.:
0
AF XY:
0.0455
AC XY:
1
AN XY:
22
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0909
AC:
2
AN:
22
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0820
AC:
12231
AN:
149108
Hom.:
553
Cov.:
31
AF XY:
0.0825
AC XY:
6006
AN XY:
72782
show subpopulations
African (AFR)
AF:
0.106
AC:
4373
AN:
41148
American (AMR)
AF:
0.0506
AC:
760
AN:
15032
Ashkenazi Jewish (ASJ)
AF:
0.0461
AC:
158
AN:
3428
East Asian (EAS)
AF:
0.0342
AC:
171
AN:
5006
South Asian (SAS)
AF:
0.0940
AC:
452
AN:
4806
European-Finnish (FIN)
AF:
0.110
AC:
1063
AN:
9652
Middle Eastern (MID)
AF:
0.0276
AC:
8
AN:
290
European-Non Finnish (NFE)
AF:
0.0754
AC:
5036
AN:
66766
Other (OTH)
AF:
0.0580
AC:
120
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
509
1018
1526
2035
2544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0792
Hom.:
77
Bravo
AF:
0.0755
Asia WGS
AF:
0.0730
AC:
247
AN:
3378

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
14
DANN
Benign
0.93
PhyloP100
-0.058
PromoterAI
-0.067
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113827322; hg19: chr16-56225036; API